Created at	Source	Raw Value	Validated value
Nov. 26, 2021, 10:30 p.m.	oms	Change from baseline in C-reactive protein (CRP) after treatment with C21 200 mg daily dose (100 mg b.i.d.).Timepoint: The primary endpoint will be the change in CRP from baseline to the average of the last 2 assessments during the treatment period.	Change from baseline in C-reactive protein (CRP) after treatment with C21 200 mg daily dose (100 mg b.i.d.).Timepoint: The primary endpoint will be the change in CRP from baseline to the average of the last 2 assessments during the treatment period.
Nov. 13, 2021, 5:33 p.m.	oms	N/A	N/A
Oct. 26, 2020, 8:29 a.m.	oms	Change from baseline in C-reactive protein (CRP) after treatment with C21 200 mg daily dose (100 mg b.i.d.).Timepoint: The primary endpoint will be the change in CRP from baseline to the average of the last 2 assessments during the treatment period.	Change from baseline in C-reactive protein (CRP) after treatment with C21 200 mg daily dose (100 mg b.i.d.).Timepoint: The primary endpoint will be the change in CRP from baseline to the average of the last 2 assessments during the treatment period.